US 10577344
Therapeutics targeting truncated adenomatous polyposis coli (APC) proteins
granted A61PA61P35/00
Quick answer
US patent 10577344 (Therapeutics targeting truncated adenomatous polyposis coli (APC) proteins) held by The Board of Regents of the University of Texas System expires Mon Feb 27 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Mar 03 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 27 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 31
- CPC classes
- A61P, A61P35/00